These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 26187902

  • 21. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK, Mário FM, Alves BC, Spritzer PM.
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [Abstract] [Full Text] [Related]

  • 22. Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome.
    Moran LJ, Noakes M, Clifton PM, Tomlinson L, Galletly C, Norman RJ.
    J Clin Endocrinol Metab; 2003 Feb; 88(2):812-9. PubMed ID: 12574218
    [Abstract] [Full Text] [Related]

  • 23. Pigment epithelium-derived factor, insulin sensitivity, and adiposity in polycystic ovary syndrome: impact of exercise training.
    Joham AE, Teede HJ, Hutchison SK, Stepto NK, Harrison CL, Strauss BJ, Paul E, Watt MJ.
    Obesity (Silver Spring); 2012 Dec; 20(12):2390-6. PubMed ID: 22641183
    [Abstract] [Full Text] [Related]

  • 24. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
    Cassar S, Teede HJ, Moran LJ, Joham AE, Harrison CL, Strauss BJ, Stepto NK.
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369
    [Abstract] [Full Text] [Related]

  • 25. Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome.
    Leblanc S, Battista MC, Noll C, Hallberg A, Gallo-Payet N, Carpentier AC, Vine DF, Baillargeon JP.
    Endocrinology; 2014 Sep; 155(9):3684-93. PubMed ID: 24971613
    [Abstract] [Full Text] [Related]

  • 26. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ, Laughlin GA, Bützow T, Maheshwari H, Baumann G, Yen SS.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [Abstract] [Full Text] [Related]

  • 27. Chronic central infusion of cocaine- and amphetamine-regulated transcript (CART 55-102): effects on body weight homeostasis in lean and high-fat-fed obese rats.
    Rohner-Jeanrenaud F, Craft LS, Bridwell J, Suter TM, Tinsley FC, Smiley DL, Burkhart DR, Statnick MA, Heiman ML, Ravussin E, Caro JF.
    Int J Obes Relat Metab Disord; 2002 Feb; 26(2):143-9. PubMed ID: 11850744
    [Abstract] [Full Text] [Related]

  • 28. Exercise for the treatment and management of overweight women with polycystic ovary syndrome: a review of the literature.
    Thomson RL, Buckley JD, Brinkworth GD.
    Obes Rev; 2011 May; 12(5):e202-10. PubMed ID: 20546140
    [Abstract] [Full Text] [Related]

  • 29. The impact of hyperandrogenism in female obesity and cardiometabolic diseases associated with polycystic ovary syndrome.
    Barber TM, Vojtechova P, Franks S.
    Horm Mol Biol Clin Investig; 2013 Sep; 15(3):91-103. PubMed ID: 25436736
    [Abstract] [Full Text] [Related]

  • 30. The effect of diet and exercise on markers of endothelial function in overweight and obese women with polycystic ovary syndrome.
    Thomson RL, Brinkworth GD, Noakes M, Clifton PM, Norman RJ, Buckley JD.
    Hum Reprod; 2012 Jul; 27(7):2169-76. PubMed ID: 22552687
    [Abstract] [Full Text] [Related]

  • 31. Modulatory role of food, feeding regime and physical exercise on body weight and insulin resistance.
    Kretschmer BD, Schelling P, Beier N, Liebscher C, Treutel S, Krüger N, Scholz HP, Haus A.
    Life Sci; 2005 Feb 18; 76(14):1553-73. PubMed ID: 15680166
    [Abstract] [Full Text] [Related]

  • 32. Effects of prepubertal-onset exercise on body weight changes up to middle age in rats.
    Shindo D, Matsuura T, Suzuki M.
    J Appl Physiol (1985); 2014 Mar 15; 116(6):674-82. PubMed ID: 24458753
    [Abstract] [Full Text] [Related]

  • 33. Overweight in polycystic ovary syndrome. An update on evidence based advice on diet, exercise and metformin use for weight loss.
    Ravn P, Haugen AG, Glintborg D.
    Minerva Endocrinol; 2013 Mar 15; 38(1):59-76. PubMed ID: 23435443
    [Abstract] [Full Text] [Related]

  • 34. Insulin sensitivity deteriorates after short-term lifestyle intervention in the insulin sensitive phenotype of obesity.
    Gilardini L, Vallone L, Cottafava R, Redaelli G, Croci M, Conti A, Pasqualinotto L, Invitti C.
    Obes Facts; 2012 Mar 15; 5(1):68-76. PubMed ID: 22433619
    [Abstract] [Full Text] [Related]

  • 35. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS, Middleton LJ, Jimenez M, Desai R, McMahon AC, Allan CM, Handelsman DJ, Walters KA.
    Endocrinology; 2014 Aug 15; 155(8):3146-59. PubMed ID: 24877633
    [Abstract] [Full Text] [Related]

  • 36. Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome.
    Nybacka Å, Carlström K, Ståhle A, Nyrén S, Hellström PM, Hirschberg AL.
    Fertil Steril; 2011 Dec 15; 96(6):1508-13. PubMed ID: 21962963
    [Abstract] [Full Text] [Related]

  • 37. Effects of Exercise Intervention on Preventing Letrozole-Exposed Rats From Polycystic Ovary Syndrome.
    Cao SF, Hu WL, Wu MM, Jiang LY.
    Reprod Sci; 2017 Mar 15; 24(3):456-462. PubMed ID: 27407136
    [Abstract] [Full Text] [Related]

  • 38. Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance.
    Ketel IJ, Stehouwer CD, Serné EH, Korsen TJ, Hompes PG, Smulders YM, de Jongh RT, Homburg R, Lambalk CB.
    J Clin Endocrinol Metab; 2008 Sep 15; 93(9):3365-72. PubMed ID: 18593766
    [Abstract] [Full Text] [Related]

  • 39. Diet-induced obesity exacerbates metabolic and behavioral effects of polycystic ovary syndrome in a rodent model.
    Ressler IB, Grayson BE, Ulrich-Lai YM, Seeley RJ.
    Am J Physiol Endocrinol Metab; 2015 Jun 15; 308(12):E1076-84. PubMed ID: 26078189
    [Abstract] [Full Text] [Related]

  • 40. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J, Zhu Y, Jiang Y, Cao Y.
    Gynecol Endocrinol; 2008 Jul 15; 24(7):392-8. PubMed ID: 18608522
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.